Menu
  • Home
  • Exhibit
    • Floor Plan
    • Sample of Attendees
    • Organisers Statement
  • Exhibitors 2025
  • Conference
    • Conference Programme
    • Speakers 2025
  • Posters
  • Gallery
  • News

Beckman Coulter Announces Development of Tests to Detect Coronavirus Antibodies

BREA, CALIF., March 31, 2020 — In response to the global COVID-19 pandemic, Beckman Coulter today announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be designed for use on any of its high- throughput Access family of immunoassay systems, including the Access 2 and DxI series installed globally.

Click here to find out more

Principal Sponsor

Main Sponsor

0 0
Weeks
0 0
Days
0 0
Hours
0 0
Minutes
0 0
Seconds
2025-03-19 09:002025-03-20 16:00Europe/LondonAttending BioMedicaBioMedicaVirtual

Organised by:
ACSLM
Email: kirstenhill@stepex.com
Website: https://acslm.ie/

© BioMedica 2025. All rights reserved. WordPress site by Miramedia

This site uses cookies. By browsing this website you agree to our use of cookies. Find out more